Company / Net Income
Co-Diagnostics, Inc. Net Income History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$46.9M
FY2025
5-year range
-$46.9M / $42.5M
FY2021-FY2025
Trend
-24.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income has declined for 4 consecutive years, from $42M in FY2021 to -$47M in FY2025.
Based on SEC 10-K filings.
-$47M in FY2025.
Declined from -$35M to -$47M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Co-Diagnostics, Inc.'s net income has declined for 4 consecutive years.
- In FY2025, net income decreased 24.6% year-over-year.
- Peak net income was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$46.9M | -24.6% |
| FY2024 | -$37.6M | -6.5% |
| FY2023 | -$35.3M | -196.4% |
| FY2022 | $36.7M | -13.7% |
| FY2021 | $42.5M | +785.6% |
| FY2020 | -$6.2M | +1.2% |
| FY2019 | -$6.3M | +9.9% |
| FY2018 | -$7.0M | -260.8% |
| FY2017 | -$1.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026